European Union - English - EMA (European Medicines Agency)

amgen europe bv - apremilast - arthritis, psoriatic; psoriasis - immunosuppressants - psoriatic arthritisotezla, alone or in combination with disease modifying antirheumatic drugs (dmards), is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior dmard therapy.psoriasisotezla is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen and ultraviolet-a light (puva).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

celgene ltd - apremilast - tablet - 30mg

Malta - English - Medicines Authority

adalvo limited malta life sciences park, building 1, level 4 sir temi zammit san gwann industrial est, sgn 3000 san gwann, malta - film-coated tablet - apremilast 20 mg apremilast 30 mg apremilast 10 mg - immunosuppressants

Malta - English - Medicines Authority

adalvo limited malta life sciences park, building 1, level 4 sir temi zammit san gwann industrial est, sgn 3000 san gwann, malta - film-coated tablet - apremilast 30 mg - immunosuppressants

Canada - English - Health Canada

amgen canada inc - apremilast; apremilast; apremilast - tablet - 10mg; 20mg; 30mg - apremilast 10mg; apremilast 20mg; apremilast 30mg - disease-modifying antirheumatic agents

Canada - English - Health Canada

amgen canada inc - apremilast - tablet - 30mg - apremilast 30mg - disease-modifying antirheumatic agents

Israel - English - Ministry of Health

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

Israel - English - Ministry of Health

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

Israel - English - Ministry of Health

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).

Israel - English - Ministry of Health

amgen europe b.v. - apremilast - film coated tablets - apremilast 10 mg - apremilast - otezla is indicated:- for treatment of adult patients with active psoriatic arthritis (psa).- for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy (psor).- for the treatment of adult patients with oral ulcers associated with behçet’s disease (bd).